HIGHLIGHTS WEBCASTS EARNINGS CONFERENCES SPLITS IPOs ECONOMIC EVENTS DIVIDENDS
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc.
INVESTOR EVENTS SNAPSHOT PRESS RELEASES FINANCIAL REPORTS REQUEST INFO
       HOME | PROFILE | GOVERNANCE | SHAREHOLDER AND ANALYST INFO Back to Directory   


 

Idera Pharmaceuticals Announces FDA Authorization to Proceed with a Phase 2 Clinical Trial of IMO-3100 in Patients with Psoriasis

 
  Message From The Company
This information is not currently provided by Idera Pharmaceuticals, Inc..
  Our Most Recent Webcast
This information is not currently provided by Idera Pharmaceuticals, Inc..
  Our Most Recent Annual Report
SYMBOL REPORT TITLE  DATE FORMAT
IDRA 2010 Annual Report 2-May-2011
 
© 2013 Thomson Reuters. All Rights Reserved.    Terms of Use.   Privacy Statement.
Send questions, comments or suggestions to tfretail@thomson.com.    Earnings dates, Webcast Events, and Conference data provided by Thomson Reuters.